在多发性骨髓瘤中,CREB1促进免疫检查点HLA-E的表达,导致免疫逃脱
Aya Ismael1, Allen J Robinette1, Laila Huric1
1Division of Hematology, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH, USA.
Leukemia
|June 20, 2024
概括
多发性髓瘤细胞通过HLA-E逃避免疫攻击.抑制CREB1转录因子减少HLA-E,恢复自然杀手细胞对抗癌症的活性.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 细胞在瘤微环境 (TME) 中逃避抗瘤免疫.
- 非经典的MHC I类分子HLA-E被确定为免疫逃避的关键因素.
- HLA-E表达与侵略性MM特征相关,并由IFN-γ诱导.
研究的目的:
- 为了研究HLA-E在多发性骨髓瘤免疫逃生中的作用.
- 确定MM中HLA-E表达的调节机制.
- 评估针对HLA-E调节的治疗潜力.
主要方法:
- 与MM疾病特征相关的HLA-E表达的分析.
- 研究转录因子CREB1.1对HLA-E的调节.
- 评估CREB1抑制对HLA-E水平和NK细胞活性的影响.
- 使用基因组和药理学抑制策略.
主要成果:
- HLA-E表达与侵略性的MM特征有关.
- CREB1直接与HLA-E促进体结合,调节其表达.
- 抑制CREB1降低了HLA-E水平,即使在IFN-γ刺激.
- 向CREB1恢复了自然杀手细胞 (NK) 介导的对MM细胞的细胞毒性.
结论:
- 在多发性髓瘤中,CREB1是HLA-E表达的关键调节者.
- 抑制CREB1代表了一种有希望的策略,以克服MM的免疫逃脱.
- 准CREB1-HLA-E轴通过重新激活NK细胞来增强抗瘤免疫力.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K


